| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10800502 | Biochimica et Biophysica Acta (BBA) - General Subjects | 2013 | 7 Pages |
Abstract
This observed activity profile suggests honokiol as promising new pharmaceutical lead or dietary supplement to combat metabolic disease, and provides a molecular explanation for the use of Magnolia in traditional medicine.
Keywords
AMPKTR-FRETSREBPRXRNBSFCSATCCPPARγEC50TCMmTORTLCGSTeGFPMEFLBDPBSSPFNF-κBIBMXDMEMnuclear magnetic resonance3-isobutyl-1-methylxanthineBSADMSODulbecco's modified Eagle's mediumNOxbovine serum albuminTime-resolved fluorescence resonance energy transferBADGEbisphenol A diglycidyl etherMetabolic diseaseanalysis of varianceANOVANMRstandard error of the meanligand-binding domainDimethyl sulfoxidenewborn bovine serumfetal calf serumtraditional Chinese medicineeffective concentration 50%nuclear factor κBNatural productPhosphate buffered salineAmerican Type Culture CollectionSEMBMPmouse embryonic fibroblastsmammalian target of rapamycinspecific pathogen freesterol regulatory element binding proteinenhanced green fluorescent proteinbone morphogenic protein 4sodium carboxymethyl cellulosethin layer chromatographyhigh-performance liquid chromatographyHPLCAMP-activated kinasePeroxisome proliferator-activated receptor gammaglutathione-S-transferaseretinoic X receptorperoxisome proliferator-activated receptor
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Atanas G. Atanasov, Jian N. Wang, Shi P. Gu, Jing Bu, Matthias P. Kramer, Lisa Baumgartner, Nanang Fakhrudin, Angela Ladurner, Clemens Malainer, Anna Vuorinen, Stefan M. Noha, Stefan Schwaiger, Judith M. Rollinger, Daniela Schuster, Hermann Stuppner,